Registration number:
Cancer, Genomics and Consulting Ltd
for the Year Ended 30 June 2023
Cancer, Genomics and Consulting Ltd
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Unaudited Financial Statements |
Cancer, Genomics and Consulting Ltd
Company Information
Director |
Dr Alexander Aresh Azizi |
Registered office |
|
Accountants |
|
Cancer, Genomics and Consulting Ltd
(Registration number: 13515820)
Balance Sheet as at 30 June 2023
2023 |
2022 |
|
Current assets |
|
|
Creditors: Amounts falling due within one year |
( |
( |
Total assets less current liabilities |
|
|
Accruals and deferred income |
( |
( |
|
|
|
Capital and reserves |
|
|
Staff numbers |
The average number of persons employed by the company (including the director) during the year, was
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Director's responsibilities:
• |
|
• |
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Approved and authorised by the
......................................... |
For the financial year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.